MilliporeSigma Brings Biotechs Closer to Drug Therapy Production and Commercialization
News Release June 5, 2018 Your Contact: Karen Tiano +1 978 495 0093 MilliporeSigma Brings Biotechs Closer to Drug Therapy Production and Commercialization Opens North America’s first BioReliance® End-to-End Biodevelopment Center to help customers with biopharmaceutical manufacturing processes Accelerates clinical development from DNA to market “Advance Biotech Grant Program” expands global biotech commitment to help... Read more